Welcome to LookChem.com Sign In|Join Free

CAS

  • or

180975-51-3

Post Buying Request

180975-51-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

180975-51-3 Usage

Uses

cis-Hexahydropyrrolo[3,4-b]pyrrole-5-carboxylic Acid tert-Butyl Ester is used in preparation of Pyridoindole for the treatment and prophylaxis of bacterial infection.

Check Digit Verification of cas no

The CAS Registry Mumber 180975-51-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,0,9,7 and 5 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 180975-51:
(8*1)+(7*8)+(6*0)+(5*9)+(4*7)+(3*5)+(2*5)+(1*1)=163
163 % 10 = 3
So 180975-51-3 is a valid CAS Registry Number.
InChI:InChI=1/C11H20N2O2/c1-11(2,3)15-10(14)13-6-8-4-5-12-9(8)7-13/h8-9,12H,4-7H2,1-3H3/t8-,9+/m0/s1

180975-51-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name (cis)-5-Boc-Hexahydro-pyrrolo[3,4-b]pyrrole

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:180975-51-3 SDS

180975-51-3Relevant articles and documents

DOPAMINE D3 RECEPTOR ANTAGONISTS HAVING A BICYCLO MOIETY

-

Paragraph 0637; 0638, (2017/02/28)

The disclosure provides compounds having formula (I), wherein the substituents are as defined herein. The compounds are useful for modulating the dopamine D3 receptor and for treating conditions associated therewith, such as addictions, drug dependency, and psychiatric conditions.

Modulators of chemokine receptor activity

-

, (2008/06/13)

Chemokine receptor antagonists, in particular, bicyclic diamine compounds of Formula (I) that act as antagonists of chemokine CCR2 and CCR3 receptors including pharmaceutical compositions and uses thereof to treat or prevent diseases associated with monocyte accumulation, lymphocyte accumulation or leucocyte accumulation are described herein.

Diazabicyclic central nervous system active agents

-

, (2008/06/13)

Compounds of formula I pharmaceutical compositions of these compounds, and use of said compositions to control synaptic transmission in mammals.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 180975-51-3